Skip to content

Kluwer Patent Blog

Kluwer Patent Blog
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
(Cross-border) jurisdiction, (Indirect) infringement, Account of profits, Case Law, Damages, Netherlands

Primus v. Roche, Court of Appeal The Hague (Gerechtshof Den Haag), 21 August 2012

Peter Burgers (Brinkhof)/October 14, 2012

The Court of Appeal held that Roche c.s. infringed the patent. Test results regarding the allegedly infringing product were admitted as evidence because Roche’s arguments were held insufficient to render these tests unreliable. Furthermore, the court ruled that it has jurisdiction to decide on the infringement in Germany based on Art. 24 EC 44/2001, because the amended German part of the patent was held valid by final judgment between the same parties in Germany.

Click here for the full text of this case.

A summary of this case will be posted on http://www.KluwerIPCases.com


_____________________________

To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.


Kluwer IP Law

The 2022 Future Ready Lawyer survey showed that 79% of lawyers think that the importance of legal technology will increase for next year. With Kluwer IP Law you can navigate the increasingly global practice of IP law with specialized, local and cross-border information and tools from every preferred location. Are you, as an IP professional, ready for the future?

Learn how Kluwer IP Law can support you.

Kluwer IP Law
This page as PDF
Like? Share with your friends.FacebookTwitterLinkedInEmail

Post navigation

Next Article

II Medinol Ltd v. Abbott Ireland and Abbot Vascular International BCBA & Others, High Court, Commercial List Dublin (High Court, Commercial List Dublin), 27 May 2011

Shane O'Brien (Mccann Fitzgerald)/October 15, 2012

Previous Article

Lundbeck / Tiefenbacher, Ratiopharm, Teva Pharma, Court of Appeal Brussels (Hof van Beroep te Brussel), 14 February 2012

Florence Verhoestraete/October 14, 2012

Get Blog Posts in your Inbox!

Go to posts on

(Compulsory) license (Cross-border) jurisdiction (Indirect) infringement Amendments Biologics Brexit Case Law Chemical Engineering Damages Denmark Enforcement EPC EPO EPO Decision Equivalents European Union Exceptions to patentability Extent of Protection France Germany Infringement Injunction Inventive step Italy Litigation Netherlands Novelty Opposition Patents Pharma Pharmaceutical patent Procedure Revocation Scope of protection Second Medical Use SEP Spain SPC Sufficiency of disclosure Switzerland Unitary Patent United Kingdom United States of America UPC Validity

Number 3 in Top 10 Pharma Patent Blogs To Follow in 2022!

Pharma Patent Blogs

Blog Contributors

  • Brian Cordery
    Bristows
  • Rik Lambers
    Brinkhof
  • Daniela Ampollini
    Trevisan & Cuonzo
  • Thorsten Bausch
    Hoffmann Eitle
  • John Collins
    Clayton Utz
  • Matthieu Dhenne
    Ipsilon
  • Simon Holzer
    MLL Meyerlustenberger Lachenal Froriep Ltd.
  • Binxin Li
    Baker & McKenzie FenXun (FTZ)
  • Vaishali Mittal
    Anand and Anand
  • Miquel Montañá
    Clifford Chance
  • Roberto Rodrigues Pinho
    Licks Attorneys
  • Alexa von Uexküll
    Vossius & Partner
  • Anders Valentin
    Bugge Valentin
VAEPC-2021Vissers Annotated European Patent Convention 2022 EditionKaisa Suominen, Peter de Lange, Andrew Rudge€ 105
10059161-0002_OR2_290_1669279860815Guide to EU and UK Pharmaceutical Regulatory Law, Eighth EditionSally Shorthose€ 265
10091699-0001_OR2_290_1655873530857The Digital Economy and International Trade: Transnational Data Flows RegulationRobert Walters€ 139

Kluwer IP Law News Alert

Stay informed on Intellectual Property law & developments

Search Posts

RSS feeds

Summary Feed Article Feed

Related Sites

  • Kluwer IP Law
  • Kluwer Copyright Blog
  • Kluwer Trademark Blog
  • Regulating for Globalization Blog
  • Author Portal
Kluwer Logo

About us

  • About Kluwer Patent Blog
  • Kluwer IP Law
  • Kluwer Law International
  • E-store
  • Authors

Legal policy

  • User Agreement and Disclaimer
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies

Contact

  • General Information
Back to top